NEURAXON
NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.
NEURAXON
Industry:
Biotechnology Neuroscience Therapeutics
Founded:
2004-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.neuraxon.com
Total Employee:
11+
Status:
Active
Contact:
416-673-6697
Total Funding:
57.41 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region Microsoft Word
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
BDC Venture Capital
BDC Venture Capital investment in Debt Financing - NeurAxon
Delphi Ventures
Delphi Ventures investment in Debt Financing - NeurAxon
Ventures West
Ventures West investment in Debt Financing - NeurAxon
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Debt Financing - NeurAxon
H.I.G. Capital
H.I.G. Capital investment in Debt Financing - NeurAxon
Lawrence Bloch
Lawrence Bloch investment in Debt Financing - NeurAxon
The Ontario Capital Growth
The Ontario Capital Growth investment in Debt Financing - NeurAxon
OrbiMed
OrbiMed investment in Debt Financing - NeurAxon
NeuroVentures
NeuroVentures investment in Debt Financing - NeurAxon
NeuroVentures
NeuroVentures investment in Series B - NeurAxon
Newest Events participated
Official Site Inspections
http://www.neuraxon.com
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149